Ogbuoji, Osondu

Global health 2050: the path to halving premature death by mid-century

Jamison, D. T., Summers, L. H., Chang, A. Y., Karlsson, O., Mao, W., Norheim, O. F., Ogbuoji, O., Schäferhoff, M., Watkins, D., Adeyi, O., et al. (2024) · The Lancet

Global Health Care IssuesGlobal Health and Epidemiology

Cited by 125

Alma Ata at 40 years: reflections from the Lancet Commission on Investing in Health

Watkins, D. A., Yamey, G., Schäferhoff, M., Adeyi, O., Alleyne, G., Alwan, A., Berkley, S., Feachem, R., Frenk, J., Ghosh, G., et al. (2018) · The Lancet

Global Health Care IssuesHealthcare Systems and Reforms

Cited by 105

The impact of continuous quality improvement on coverage of antenatal HIV care tests in rural South Africa: Results of a stepped-wedge cluster-randomised controlled implementation trial

Yapa, H. M., De Neve, J.-W., Chetty, T., Herbst, C., Post, F. A., Jiamsakul, A., Geldsetzer, P., Harling, G., Dhlomo-Mphatswe, W., Moshabela, M., et al. (2020) · PLOS Medicine

Health Policy Implementation ScienceHIV/AIDS Research and Interventions

Cited by 31

Achieving global mortality reduction targets and universal health coverage: the impact of COVID-19

Mao, W., Ogbuoji, O., Watkins, D., Bharali, I., Nsiah-Boateng, E., Diab, M. M., Dwomoh, D., Jamison, D. T., Kumar, P., Kennedy McDade, K., et al. (2021) · PLOS Medicine

Healthcare Systems and ReformsGlobal Maternal and Child Health

Cited by 18

Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries

Schäferhoff, M., Zimmerman, A., Diab, M. M., Mao, W., Chowdhary, V., Gill, D., Karanja, R., Madikizela, M., Ogbuoji, O., & Yamey, G. (2022) · The Lancet Global Health

Pharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life

Cited by 11

Economic consequences of better health: insights from clinical data

Ogbuoji, O., Vollmer, S., Jamison, D. T., & Bärnighausen, T. (2020) · BMJ

Health Systems, Economic Evaluations, Quality of LifeGlobal Health Care Issues

Cited by 8

Impact of immediate initiation of antiretroviral therapy on HIV patient satisfaction

Ogbuoji, O., Geldsetzer, P., Wong, C., Khan, S., Mafara, E., Lejeune, C., Walsh, F., Okello, V., & Bärnighausen, T. (2020) · AIDS

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 8

A stepped-wedge randomised trial on the impact of early ART initiation on HIV-patients’ economic outcomes in eswatini

Steinert, J. I., Khan, S., Mlambo, K., Walsh, F. J., Mafara, E., Lejeune, C., Wong, C., Hettema, A., Ogbuoji, O., Vollmer, S., et al. (2020) · eLife

HIV/AIDS Research and InterventionsHIV/AIDS Impact and Responses

Cited by 7

The impact of immediate initiation of antiretroviral therapy on Patients’ healthcare expenditures: a stepped-wedge randomized trial in eswatini

Steinert, J. I., Khan, S., Mafara, E., Wong, C., Mlambo, K., Hettema, A., Walsh, F. J., Lejeune, C., Mazibuko, S., Okello, V., et al. (2021) · AIDS and Behavior

HIV/AIDS Research and InterventionsHIV/AIDS Impact and Responses

Cited by 6